WELL Health Technologies Corp (WELL) Fair Value & Analysis
Healthcare · CA · Market cap C$1.2B
Fair value as of: Jun 25, 2026
From 13 valuation models · updated 4 days ago
Fair value updated Jun 25, 2026 — revised from C$7.90 to C$5.26 (−33.4%) since Jun 24, 2026. Share price −4.8% over the past month.
Price vs Fair Value (12 months)
12‑month range C$3.61 – C$5.95 · fair‑value band C$3.21 – C$7.14 · the C$4.13 price screens below the C$5.26 fair value. As of Jun 25, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
WELL Health Technologies Corp (WELL) currently trades at C$4.13, while our model-based Fair Value estimate is C$5.26 — implying the stock looks roughly 27.4% undervalued today. We read business quality at 83/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, WELL Health Technologies Corp generated revenue of C$1.5B at a net margin of 1.8%. Revenue grew 25.2% year over year. It earns a return on equity of 4.2%. Net debt stands at C$577M. Fundamentals as of Jun 25, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 25, 2026. TTM = trailing twelve months.
About the company
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women's health, primary care, and behavioural health. It also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, the company operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); billing and revenue cycle management solutions, such as DoctorCare, ClinicAid, and PatientServ; OceanMD, an EMR-integrated patient engagement solutions; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, AwareMD, and Healthquest EMR systems. WELL H…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
WELL Health Technologies Corp reported revenue of C$1.4B in FY2025 versus C$302M in FY2021, a compound +46.7%/yr. Reported net income was −C$50.2M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$96.00 | R$25.67 | -73% |
| Fresenius SE FSNUY | $11.47 | $8.55 | -25% |
| 5225 5225 | 8.70 MYR | 2.61 MYR | -70% |
| IHHHF IHHHF | $1.71 | $1.17 | -32% |
| Tenet Healthcare Corporation THC | $162.06 | $282.55 | +74% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.76 | R$30.33 | -7% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is WELL Health Technologies Corp (WELL) undervalued?
What is the fair value of WELL?
What is the quality score of WELL?
What is the revenue of WELL Health Technologies Corp (WELL)?
What is the net profit margin of WELL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.